Poster session 3. Hypercoagulation and thrombo/hemorrhagic risk biomarkers
PO-35 Loss of angiogenic activity and improvement of hemostatic variables in patients with gastrointestinal stromal tumors (GIST) under Imatinib therapy: a biological evaluation